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Background  The need for transvenous lead extraction procedures of coronary sinus (CS) leads is increasing due to 
rising numbers of implanted cardiac resynchronization therapy devices during the past decade. 
Methods  From January 2009 to June 2013, 27 CS leads were scheduled for extraction in 27 patients (mean age 
(63.1±14.6) years). Indications for lead extraction were infection in 13 and lead dysfunction in 14 cases. Isolated extraction 
of CS leads was performed in eight, extraction of multiple leads in 19 cases. Among leads with an implant time of ≥12 
months (n=19) mean implant duration (MID) was (46.4±15.2) (12–76) months. Groups were formed depending on 
infectious or non-infectious indications (INF vs. Non-INF), and the use or non-use of extraction tools (ET1 vs. ET0).
Results  Among patients with an implant duration of ≥12 months, complete procedural success was 94.7% and clinical 
success 100%. Operative mortality was zero. In the INF versus NON-INF groups complete procedural success (100% 
vs. 91.7%, P=0.43), mean number of required extraction tools (0.7 (0–2) vs. 0.9 (0–3), P=0.65) and MID (49.1±15.0 vs. 
44.7±15.8, P=0.83) did not differ significantly. Comparing the groups ET1 and ET0 showed no significant differences in 
complications (n=1 vs. n=1, P=0.81) and MID (47.0±17.5 vs. 45.5±12.6, P=0.71). 
Conclusions  In specialized centers transvenous lead extraction of coronary sinus leads with a mean implant duration of 
almost four years can be performed safely and effectively. Neither non-infectious indications nor the use of extraction tools 
negatively affected the outcome of the procedure.
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The number of implanted cardiac resynchronization therapy (CRT) devices has increased enormously 
during the last decade. At present approximately 100 000 
CRT devices are implanted yearly in Europe with regional 
differences.1 Given the need for lead extractions, which 
was estimated as 1.5%–6% in the position paper of the 
European Heart Rhythm Association (EHRA), this would 
mean 1500–6000 extractions of coronary sinus (CS) 
leads per year in Europe.2 In general, transvenous lead 
extraction procedures can currently be carried out with 
high success rates and low complication rates.3-7 Most 
reported experiences with extraction procedures refer to 
the removal of right atrial or right ventricular leads with 
few studies investigating the extraction of CS leads. In this 
retrospective study we analyzed our extraction experience 
of CS leads with regard to indications, extraction tools, 
success, and complication rates.
METHODS
Patient population
All transvenous lead extraction procedures performed 
between January 2009 and June 2013 were screened. In 
this time interval 152 patients underwent lead extraction 
procedures with 259 leads scheduled for extraction. 
Patients were included if coronary sinus lead extraction 
was performed. Twenty-seven patients (18 male, 9 female) 
with 27 coronary sinus leads scheduled for extraction were 
identified. Mean age was (63.1±14.6) years, range 29–90 
years.
All CS leads were passive fixation leads. Indication for 
extraction was infection in 13 cases and non-functional 
leads in 14 cases. Isolated extraction of CS leads was 
performed in eight cases, extraction of multiple leads in 19 
cases. For statistical analysis, leads with an implant time of 
12 months and more were selected (n=19). Among these 
leads the mean implant time was (46.4±15.2) months, range 
12–76 months. Groups were formed based on infectious 
(n=7) or non-infectious (n=12) indication and the necessity 
to use extraction tools (n=11) or extraction without tools 
(n=8).The preoperative patient and lead data are displayed 
in Table 1. 
Appropriate institutional review board approval was 
obtained. The results of the different groups were analyzed 
and compared.
Extraction procedure
If leads could not be extracted by simple traction, a staged 
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approach was performed. Access to the lead scheduled 
for extraction was obtained by a superior, subclavian 
approach. After freeing the lead of the fibrotic adhesions 
in the generator pocket, the fixation sutures of the lead 
were removed. For application of traction, as a first step, 
a locking stylet was used (Liberator, Cook Medical, USA 
or Lead Lock Device, Spectranetics, USA). In cases 
where traction with the locking stylet was not sufficient, 
counterpressure or countertraction using powered or 
non-powered extraction sheaths was added. To apply 
counterpressure or countertraction, polypropylene 
extraction sheaths (Byrd Dilator Sheath, Cook Medical, 
USA) were first used in a telescoping sheath technique. 
If not successful a further step with a mechanical dilator 
sheath (Evolution, Cook Medical, USA) or a laser sheath 
(SLS II, Spectranetics, USA) was performed. Beginning in 
December 2010 the mechanical dilator sheath was primarily 
applied, before that date the laser sheath was used regularly. 
In case of failed or impossible subclavian approach, a 
femoral snare extraction technique was performed using 
the Needle’s Eye Snare device (Cook Medical, USA) 
via the right femoral vein (Figure 1). Lead extraction 
procedures were performed in an operation theater with 
general anesthesia by a cardiac surgeon with standby of 
extracorporeal circulation. Patients were continuously 
monitored by electrocardiogram (ECG), invasive blood 
pressure measurement, pulse oximetry, and transesophageal 
echocardiography. Success was defined either as complete 
procedural success or as clinical success according to the 
definitions of the expert consensus on transvenous lead 
extraction by the Heart Rhythm Society.8
Statistical analysis
Data were analyzed using the SPSS software Version 
20.0 (IBM Corporation, USA). Categorical variables are 
presented as numbers and percentages. Differences between 
groups were analyzed using the Chi square test. Continuous 
variables are presented as mean ± standard deviation or 
as mean and range from minimum to maximum. Mann-
Whitney U test for independent samples was performed to 
analyze the differences between groups. A P-value of less 
than 0.05 was considered significant.
RESULTS
Among leads with an implant duration of at least 12 months 
the complete procedural success rate was 94.7% and 
clinical success 100%. Operative mortality was zero. One 
major complication occurred in a multiple lead extraction 
procedure, which was not related to the extraction of the 
coronary sinus lead. The patient suffered from a right 
ventricular tear after extraction of a right ventricular ICD 
lead and required an emergency thoracotomy. The patient 
survived. One pocket hematoma requiring surgical drainage 
was noted as a minor complication. No coronary sinus 
complications were seen.
Infectious versus non-infectious indications
When analyzing the results with regard to infectious (INF) 
or non-infectious (NON-INF) indications, it was noted that 
mean implant duration was not significantly different in 
the two groups; INF vs. NON-INF: (49.1±15.0) months 
vs. (44.7±15.8) months (P=0.83). The rates of complete 
procedural success showed no significant difference 
between the two groups (P=0.43) being 100% in the INF 
group and 91.7% in the NON-INF group. The mean number 
of required extraction tools was 0.7 (0–2) tools in the group 
INF and 0.9 (0–3) tools in the NON-INF group; with no 
statistically significant difference (P=0.65) (Table 2). In the 
INF group no immediate re-implantation of coronary sinus 
Table 1. Preoperative patient and lead data
Characteristics Preoperative value
Patients (n) 27
Gender (n)
Male
Female
18 
9
Mean patient age (years) 63.1 (29–90) 
Leads overall (n)
Leads ≥12 months ID (n)
27
19
MID all leads (months)
MID leads ≥12 months ID (months)
33.3 (1–76) 
46.4 (12–76) 
Indication for lead extraction (n)
Infection
Dysfunctional lead
13
14
Isolated vs. multiple lead extractions (n)
Isolated CS lead extraction
Multiple lead extraction
8
19
Underlying disease (n)
Dilated cardiomyopathy
Ischemic cardiomyopathy
21
6
Ejection fraction prior to lead extraction procedure (%) 37.1±13.3 
Left ventricular end-diastolic diameter prior to 
  lead extraction procedure (mm)
62.8±12.0
Figure 1. Extraction of a coronary sinus lead using a femoral snare device (Needle’s Eye Snare, Cook Medical).
Figure 2. Due to their design with mostly smaller diameters of the lead body compared to right atrial and right ventricular leads, coronary 
sinus leads are physically less resistant to extraction forces and therefore have a higher risk for lead rupture during the extraction procedure.
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leads was performed. Among the patients of the NON-INF 
group (n=12) a re-implantation of a coronary sinus lead 
was attempted in seven cases with success in all cases. In 
three patients an epicardial left ventricular lead was directly 
implanted without attempting transvenous implantation.
Use of extraction tools
With regard to the use of extraction tools, mean implant 
duration did not show significant differences between the 
two extraction tools groups; ET1 (47.0±17.5) months vs. 
ET0 (45.5±12.6) months (P=0.71). Also the number of 
complications was low and revealed no differences; ET1 
n=1 vs. ET0 n=1 (P=0.81) (Table 3). The distribution of 
the number of extraction tools used with the corresponding 
number and percentage of leads,  as well  as the 
corresponding mean implant duration, is displayed in Table 
4.
DISCUSSION
There are several special aspects to lead extractions of CS 
leads which may lead to an increased difficulty of such 
procedures. The design of CS leads is different from right 
atrial and right ventricular leads with smaller diameters of 
the lead body in most cases and, therefore, less physical 
resistance to extraction forces and a higher risk for lead 
rupture (Figure 2). In order to avoid lead damage the 
application of counterpressure or countertraction for CS 
lead extraction has to be performed more carefully in 
comparison to extraction of right atrial or right ventricular 
leads. Lead-lead-interactions may also be encountered 
during extraction procedures of CS leads, which can 
necessitate the extraction of other leads not scheduled for 
removal. Furthermore, venous stenosis or occlusion may be 
encountered more frequently due to the higher number of 
implanted leads.9,10
Due to the large numbers of  implanted cardiac 
resynchronization therapy devices in heart failure patients, 
an increasing number of coronary sinus lead extractions 
may be expected in the coming decade.1,2 There are many 
studies investigating the extraction of right atrial or right 
ventricular leads, however investigations of transvenous 
extraction procedures of coronary sinus leads have been 
published less frequently.6,7,11-14 Most studies addressing 
coronary sinus lead extraction have investigated leads with 
a mean implant duration of 30 months or less.13-17 In our 
study, mean implant duration of the leads was 46 months, 
ranging from 12 to 76 months. Even though the mean 
implant duration was longer than in the studies mentioned 
above, our rates of complete procedural success and clinical 
success compare favorably with the success rates in the 
published data. This fact should not lead to the assumption 
that the success of extraction procedures of transvenous left 
ventricular leads will stay high despite increasing implant 
durations, since it was shown in other lead extraction 
studies that success rates begin to decrease significantly 
with implant duration of ten years and more.5,7,12,18 With the 
results from other investigations in mind, we might still 
be facing a challenging extraction procedures of coronary 
sinus lead procedures in the future. In contrast, transvenous 
extraction of active fixation coronary sinus leads 
(Medtronic Starfix®) are known to be more challenging 
even in cases with short duration implants.16,17
When analyzing the data of infectious or non-infectious 
indications for lead extraction, we were able to show 
that the difficulty (expressed by the mean number of 
extraction tools) and success of the operation did not differ 
significantly, and the mean implant duration was similar 
in both groups. This is in contrast to the data of Byrd et 
al18 on lead extractions of right atrial and right ventricular 
leads. They reported that the risk of incomplete or failed 
extraction increased with non-infected patients, among 
other factors. It is important, however, to mention that the 
data in Byrd’s study are from almost twenty years ago. 
Currently, several improved high-end extraction tools 
have been introduced for clinical application, which has 
certainly improved success rates, even in difficult cases 
with extensive lead fibrosis.7,19,20
Lead extraction is known to be a safe procedure with 
current techniques.6,11,21 Despite this fact, in a small 
percentage of cases, major, and possibly life-threatening, 
complications can occur during such operations, possibly 
related to the use of extraction tools.22 In extraction of 
transvenous left ventricular leads this may be relevant due 
to the anatomical position of the lead. The coronary venous 
system is more fragile than myocardial tissue of the right 
ventricle or the right atrium. Therefore we analyzed our 
results with regard to the use or the non-use of extraction 
Table 2. Results of extraction procedures of leads with ≥12 months 
implant duration with regard to indication
Characteristics
INF 
(7 leads)
Non-INF 
(12 leads)
P values
Patient age (years) 67.2±6.5 60.3±16.4 0.48
Gender (%)
Male
Female
57.1
42.9
75.0 
25.0
0.41
Mean implant duration (months) 49.1±15.0 44.7±15.8 0.83
Complete procedural success (n (%)) 7 (100.0) 11 (91.7) 0.43
Mean number of required extraction tools 0.7 (0–2) 0.9 (0–3) 0.65
INF: infectious indication; NON-INF: non-infectious indication.
Table 3. Results of extraction procedures of leads with ≥12 months 
implant duration with regard to the use of extraction tools 
Characteristics ET1 (11 leads) ET0 (8 leads) P values
Patient age (years) 61.2±14.3 65.3±13.7 0.60
Gender (%)
Male
Female
54.5 
45.5
87.5 
12.5
0.12
Mean implant duration (months) 47.0±17.5 45.5±12.6 0.71
Complications (n) 1 1 0.81
ET1: use of extraction tools; ET0: extraction without tools.
Table 4. Distribution of the number of extraction tools used with 
regard to mean implant duration in leads with ≥12 months implant 
duration
Characteristics
Number of extraction tools used
0 1 2 3
Number of leads (n (%)) 8 (42.1) 7 (36.8) 3 (15.8) 1 (5.3)
Mean implant duration (months) 45.5±12.6 42.9±17.5 54.3±21.0 54.0±0
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tools. Implant duration did not differ significantly between 
these two groups and complication rates were low in 
both groups without differences. Complications related 
to the coronary venous system were not seen. Of course, 
the results of complications need to be interpreted very 
carefully since the numbers are small. In addition, reported 
general rates of major complications mostly vary between 
0% and 4%, which from a statistical standpoint necessitates 
large patient populations to draw solid conclusions from 
comparisons of different groups.4,6
Limitations of this study are its retrospective design, 
the fact that it is a single-center experience and the 
small size of the patient population. Studies with larger 
patient populations should be performed in the future. In 
specialized centers transvenous lead extraction of coronary 
sinus leads with a mean implant duration of almost four 
years can be performed safely and effectively. Neither 
non-infectious indications nor the use of extraction tools 
negatively affected the outcome of the procedure. But with 
increasing implant duration, extraction of coronary sinus 
leads might become more challenging in the future.
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